Oncologix Tech Inc.
OCLG - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$166.25K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $166,247.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0 |
| Outstanding Shares | 1,662,469,227 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.03 |
|---|---|
| PEG | 0.03 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Oncologix Tech Inc.
191 employees
CEO: Michael A. Kramarz
Oncologix Tech, Inc. is a biopharmaceutical company whose main products include DNAGO and genomego which provides clinical genetic testing on all 20,000+ genes encompassing over 7,000 rare genetic diseases. It also previously operated in...